Optomed has been awarded a contract to develop an advanced IT system for the automation and evaluation of outcomes in ophthalmic care. The system is developed for the Finnish University Eye Clinics. Optomed was awarded the contract together with Carl Zeiss Oy through a public innovative procurement process.
During the development phase, Optomed will create the system together with the Finnish University Eye Clinics. The development phase revenue is expected to be approximately EUR 350.000 and it is expected to last for 18 months after which the joint municipal authorities’ Health Care Districts will separately decide upon the deployment of the new system. The serving areas of the five University Hospitals cover approximately 60 % of the Finnish population, i.e., approximately 3.3 million people. Optomed retains the intellectual property rights of the new IT system which enable its sales and productization globally.
Markku Myllylä, VP Software, comments:
‘We are very excited about this opportunity to develop the new IT system together with the Finnish ophthalmology professionals. The aces-rwm concept (automation in care and evaluation of system with real-world monitoring) designed by our clients is an innovative idea aiming to increase the effectiveness and evaluate outcomes in eye care. This project is, in accordance with Optomed’s mission, an excellent example of cost-effective and scalable solutions aiming to prevent avoidable blindness and reduce overall healthcare costs.’
Further information regarding the IT system:
The IT system is a part of the aces-rwm concept advocating a strategy to optimize real-life effectiveness, sustainability and outcomes of the service delivery in eye care. The aces-rwm concept is a collaboration ecosystem of all five Finnish University Eye Clinics, funded partly by Business Finland as an innovative public procurement. Additionally, the aces-rwm concept offers a tool for national and international benchmarking and creates a foundation for data visualization and operational integration both on patient and system levels. The principles of aces-rwm concept are adaptable to all medical specialties and primary care.
Further information regarding the public procurement:
The public procurement procedure was innovation partnership. The following parties among others submitted the requests to participate:
- Icare Finland Oy, Cinia Oy, NHG Finland Oy and Robu Oy
- Topcon Healthcare Solutions Emea Oy and BCB Medical Oy
- Optomed Software Oy and Carl Zeiss Oy
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 56 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and Optomed employed 108 professionals the end of 2019.
Professor Anja Tuulonen, Chief Physician, aces-rwm Project Leader, Tays Eye Centre, firstname.lastname@example.org
Markku Myllylä, VP Software, Optomed Plc, email@example.com